key: cord-0011651-f4v5vpxt authors: Wang, Zhi-Li; He, Yu; Luo, Zheng-Xiu title: Continuous positive airway pressure in children with severe pneumonia: a meta-analysis date: 2020-05-21 journal: World J Pediatr DOI: 10.1007/s12519-020-00366-0 sha: 30f9f8dd4536eea9368e9214f216cf40917eddb5 doc_id: 11651 cord_uid: f4v5vpxt nan (standard therapy or low-flow oxygen); and (3) involving inpatients with severe pneumonia defined by WHO younger than 18 years. Case reports, observational studies, reviews, comments, conference abstracts were excluded. The primary outcomes were the intubation rate and mortality. Secondary outcomes included the change in respiratory rate (RR), heart rate (HR), duration of hospital stay, and adverse events. Data extraction was performed independently by two reviewers. Data extracted included: study design, participants and settings, interventions, outcomes, and adverse effects. Disagreements were solved by consensus. We summarized the intervention effects by calculating risk ratios (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes; we also calculated 95% confidence interval for each outcome. Fixed-effects model or random-effects model were used to perform meta-analysis depending on the heterogeneity across studies. I 2 statistic were used for the assessment of heterogeneity, with I 2 > 50% indicating significant heterogeneity [9] . To explore the potential causes of significant heterogeneity, we performed subgroup analyses for primary outcomes if data were sufficient. The factors including age, sample size, settings, and high-risk conditions were prespecified for subgroup analyses. Sensitivity analysis was conducted by removing crossover trails and those studies without the supervision of physicians respectively. P value < 0.05 was considered statistically significant. Four studies (three RCTs [10] [11] [12] , one randomized crossover trial [13] ) with a total of 3040 patients satisfied the inclusion criteria and were included in the analysis. Descriptive data for each study are presented in Table 1 . Three studies [11] [12] [13] (n = 2971) investigated the mortality. The pooled data suggested that mortality was not significantly reduced in CPAP group with significant heterogeneity (RR: 0.75, 95%CI = 0.33, 1.73; P = 0.50, I 2 = 83%) (Fig. 1a) . The probability of intubation was reported in only one RCT [11] (n = 146), in which a trend towards reduction in intubation was found in the CPAP group, but the Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s1251 9-020-00366 -0) contains supplementary material, which is available to authorized users. difference was not statistically significant between CPAP and control groups (RR = 0.39, 95%CI 0.14, 1.05, P = 0.06) (Fig. 1b) . We conducted subgroup analyses to investigate whether effects of CPAP on mortality and intubation differed according to different age. In the subgroup analysis, no significant differences regarding mortality were found between CPAP and control groups in different age groups (children age < Fig. S1b in supplement). We did not conduct subgroup analyses based on different settings, sample size, and highrisk conditions because of the limited number of studies. Note that sensitivity analysis by removing the crossover trail or the study without the supervision of physicians seperately did not change the result of mortality (see Fig. S2a, Fig.S2b in supplement). Data for change in RR were available from only one RCT [10] (n = 69). The RR was remarkably decreased in the CPAP group after 1 h (MD = − 15.00 95%CI − 21.52, − 8.48, P < 0.00001) (Fig. 2a) . HR was observed with no significant change in the same trial [10] ; nonetheless, the lack of original data prevented us from a meta-analysis. The pooled data from one RCT [11] (n = 146) suggested there was no significant reduction in the length of hospital stay in CPAP group (MD = 0.29, 95%CI − 0.37, 0.96, P = 0.39) (Fig. 2b) . Two studies [12, 13] (n = 2825) reported the incidence of adverse events and most of the adverse events were not serious. Only one child was reported to be suffering from probable pneumothorax and four probable aspiration episodes happened in CPAP group in one study [12] . The pooled data suggested there was no significant difference in adverse events between CPAP and control groups (RR = 3.06, 95%CI 0.38, 24.98, P = 0.30, I 2 = 76%) (Fig. 2c) . The pooled data are contradictory regarding mortality. One crossover trial [13] found no significant difference in mortality between groups, but the study population was relatively low-risk; few children had hypoxemia or were severely malnourished. Another RCT [11] that recruited children with severe pneumonia and hypoxemia showed significantly lower mortality in CPAP group, but the study was done in an intensive care unit, which means higher nurse-to-patient ratios and better medical supervision. Differently, the latest and largest RCT [12] which was done in the general ward without daily physician supervision showed an increase in mortality with the use of CPAP among high-risk (such as HIV, malnutrition, or hypoxemia) children with severe pneumonia. The differences mentioned above may contribute to the inconsistent results. Notably, WHO-defined severe pneumonia is a clinical diagnosis that does not require chest radiographs to confirm the presence of lower respiratory disease. The nonspecific signs and symptoms can be found in children without primary respiratory disorders such as circulatory failure [12, 14] , which may cause the recruited participants not to be wholly homogenous in different studies. Due to heterogeneity between the studies and the conflicting results, it is difficult to conclude the effect and safety of CPAP. Limited evidence indicated that CPAP decreased the respiratory rate. There was no significant difference in intubation rate, length of hospital stay, and adverse events between the CPAP and control groups. In conclusion, data regarding safety is contradictory for the use of CPAP among children with severe pneumonia. Limited evidence suggests CPAP may reduce respiratory rate. Still, there is a lack of evidence to show significant benefit for the use of CPAP for other outcomes. More well-designed RCTs are needed to evaluate which specific patient populations could benefit from CPAP in various settings. Case reports, observational studies, reviews, comments, conference abstracts were excluded. Author contributions ZLW is responsible for the conception, data search, inclusion and exclusion of studies, data extraction, data analysis, and writing the manuscript. YH is responsible for inclusion and exclusion of studies, data extraction, checking the data of the outcomes, and writing the manuscript. ZXL is responsible for the supervision and reviewed the manuscript for important intellectual content. All authors approved the manuscript. ZLW and YH contributed equally to this manuscript. Funding No external funding for this manuscript. Ethical approval Not reqired for this paper. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals Pocket book of hospital care for children: guidelines for the management of common childhood illnesses British Thoracic Society guidelines for the management of community acquired pneumonia in children: update Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC) Complications of mechanical ventilation in the pediatric population Pediatric emergency noninvasive ventilation CPAP: a guide for clinicians in developing countries Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Measuring inconsistency in meta-analyses A randomized clinical trial evaluating nasal continuous positive Efficacy of CPAP vs. control on a respiratory rate, b duration of hospital stay, and c incidence of adverse events airway pressure for acute respiratory distress in a developing country Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial Continuous positive airway pressure for children with undifferentiated respiratory distress in Ghana: an open-label, cluster, crossover trial The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.